AbbVie Inc. et al v. Watson Laboratories Inc. - Florida > Summary
Court Case Number 1:12-cv-00324
Filing Date Mar 16, 2012
Court Delaware District Court
Status Unknown
Plaintiff Attorneys
4AbbVie Inc.
Attorney Name: Mary B. Graham
Morris Nichols Arsht & Tunnell
Defendant Attorneys
9Watson Pharma Private ltd
Attorney Name: Steven J. Fineman
Richards, Layton & Finger, P.A.
Watson Laboratories
Attorney Name: Steven J. Fineman
Richards, Layton & Finger, P.A.
Watson Laboratories
Attorney Name: David M. Fry
Shaw Keller LLP
Watson Pharma Private ltd
Attorney Name: Karen E. Keller
Shaw Keller LLP
Watson Laboratories
Attorney Name: Karen E. Keller
Shaw Keller LLP
Watson Laboratories
Attorney Name: Karen E. Keller
Shaw Keller LLP
Watson Laboratories
Attorney Name: Jaclyn Levy
Richards, Layton & Finger, P.A.
Watson Laboratories
Attorney Name: Christopher J. Sorenson
Merchant & Gould
Counter Defendant
4AbbVie Inc.
Attorney Name: Mary B. Graham
Morris Nichols Arsht & Tunnell
Counter Claimant
2Watson Laboratories
Attorney Name: David M. Fry
Shaw Keller LLP
Watson Laboratories
Attorney Name: Karen E. Keller
Shaw Keller LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 06469035 | Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid | Oct 22, 2002 |
| 06080428 | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor | Jun 27, 2000 |
